Innovation in Diagnostics Bio-Rad's recent launches of advanced diagnostic products such as the Liquichek Opiate Control and EZ-Check Salmonella demonstrate their commitment to expanding their diagnostic portfolio, presenting opportunities to cross-sell complementary testing kits and reagents to existing customers.

Educational & Research Tools The company's development of educational kits like the BacTalk Cell Signaling Kit indicates a focus on innovative learning solutions, creating potential for partnerships with academic and research institutions to promote product adoption.

Strategic Collaborations Recent partnerships, including with Complete Genomics to enhance single-cell and spatial transcriptomics, suggest opportunities to sell high-throughput sequencing instruments and reagents to genomics and biotech research labs.

Industry Engagement Participation in major events like ADLM 2025 and clinical workshops highlights Bio-Rad’s active engagement with industry professionals, which can be leveraged to introduce new products and provide targeted demos to decision-makers and laboratory managers.

Market Position & Growth With a substantial revenue exceeding one billion dollars and a strong global presence, Bio-Rad’s ongoing innovation and product launches position it as a preferred supplier for labs seeking reliable, cutting-edge diagnostic and research solutions—an opportunity to upsell advanced technologies and expand into new markets.